Biochemical recurrence of prostate cancer: the controversial recognition and management

• 作 者: XIA Shu-jie JING Yi-feng
• 机 构: Department of Urology,First People’s Hospital Affiliated to Shanghai Jiao Tong University,Shanghai 2
• 出 处: 中华医学杂志英文版
• 发表日期: 2011年124期
• 关键词: prostate cancer radiation therapy management clinically challenge medical PSA le

Over the past decaade, more and more patients diagnosed as prostate cancer have received radical management attributing to the advent of prostate-specific antigen (PSA) based medical screening.Radical prostatectomy (RP) and radiation therapy (RT) are the most commonly used forms of definitive therapy for clinically localized prostate cancer.However, despite these technique advances, biochemical recurrence (BCR),as determined by subsequent rises in the serum PSA level,is still a challenge that urologists face.